Logo

Yuhan Pharmaceutical Collaborates with Cyclica to Enhance Drug Development Utilizing AI-Integrated Drug Discovery Platform

Share this

Yuhan Pharmaceutical Collaborates with Cyclica to Enhance Drug Development Utilizing AI-Integrated Drug Discovery Platform

Shots:

  • Cyclica to receive up front and milestones on completion of specific objectives. Yuhan will leverage Cyclica’s AI integrated drug discovery platform- Ligand Design and Ligand Express in two separate R&D programs
  • Yuhan enhance its drug development efforts by utilizing AI integrated drug discovery platform across multiple therapeutic areas to develop novel therapies targeting Yuhan’s R&D interest
  • Cyclica’s Ligand Design and Ligand Express provides AI-augmented platform to design advanced lead-like molecules- minimizing unwanted off-target effects by providing a holistic understanding of its biology and structural pharmacogenomics

Click here to­ read full press release/ article | Ref: Business wire | Image: Cyclica


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions